Close
  Indian J Med Microbiol
 

Figure 1: Evaluation and therapeutic flowchart for myositis-interstitial lung disease. ADM: Amyopathic dermatomyositis, X-ray: radiography, ILD: Interstitial lung disease, HRCT: High-resolution computed tomography, RP-ILD: Rapidly progressive ILD, MDA5: Melanoma differentiation-associated gene 5, CRP: C-reactive protein, SpO2: Pulse saturation oxygen, PSL: Prednisolone, IVCY; Intravenous cyclophosphamide therapy, CNI: Calcineurin inhibitor, RTX: Rituximab, mPSL: Methyl-PSL, ARS: Aminoacyl-tRNA synthetase, FVC: Forced vital capacity, AZA: Azathioprine, MMF: Mycophenolate mofetil

Figure 1: Evaluation and therapeutic flowchart for myositis-interstitial lung disease. ADM: Amyopathic dermatomyositis, X-ray: radiography, ILD: Interstitial lung disease, HRCT: High-resolution computed tomography, RP-ILD: Rapidly progressive ILD, MDA5: Melanoma differentiation-associated gene 5, CRP: C-reactive protein, SpO<sub>2</sub>: Pulse saturation oxygen, PSL: Prednisolone, IVCY; Intravenous cyclophosphamide therapy, CNI: Calcineurin inhibitor, RTX: Rituximab, mPSL: Methyl-PSL, ARS: Aminoacyl-tRNA synthetase, FVC: Forced vital capacity, AZA: Azathioprine, MMF: Mycophenolate mofetil